Trial Profile
Phase 2 study of ACX-31 in patients with relapsed/recurrent glioblastoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Carmustine/temozolomide (Primary)
- Indications Glioblastoma
- Focus First in man; Therapeutic Use
- 24 Sep 2016 New trial record